General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-07 | 2024-03 | -0.09 | N/A | N/A | N/A |
2024-03-05 | 2023-12 | -0.08 | -0.12 | -0.04 | -50.00% |
2023-11-06 | 2023-09 | -0.11 | -0.03 | 0.08 | 72.73% |
2023-11-06 | 2023-09 | -0.11 | N/A | N/A | N/A |
2023-08-07 | 2023-06 | -0.11 | N/A | N/A | N/A |
2023-08-07 | 2023-06 | -0.11 | -0.1 | 0.01 | 9.09% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-09 | Wedbush | Upgrade | Outperform | Outperform |
2023-10-09 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-09-21 | Wedbush | Upgrade | Outperform | Outperform |
2023-09-21 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-09-20 | JMP Securities | Upgrade | Market Outperform | Market Outperform |
2023-07-30 | HC Wainwright & Co. | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-03-06 | BARBER DANIEL | Chief Executive Officer | 883.30K | Stock Award(Grant) |
2024-03-06 | BOYD PETER E | Officer | 246.00K | Stock Award(Grant) |
2024-03-06 | BRAENDER LORI J | General Counsel | 323.76K | Stock Award(Grant) |
2024-03-06 | JUNG CASSIE | Officer | 249.23K | Stock Award(Grant) |
2021-08-25 | KENDALL KEITH J. | Chief Executive Officer | 637.15K | Stock Gift |
2024-03-06 | KRAUS CARL N | Officer | 262.50K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Bratton Capital Management, LP | 9.81M | 16.19M | 14.70% |
2023-06-29 | Vanguard Group Inc | 1.56M | 2.57M | 2.34% |
2023-06-29 | Renaissance Technologies, LLC | 1.23M | 2.03M | 1.84% |
2023-06-29 | Armistice Capital, LLC | 1.16M | 1.91M | 1.74% |
2023-09-29 | Vahanian & Associates Financial Planning Inc. | 722.11K | 1.10M | 1.08% |
2023-06-29 | Bracebridge Capital, LLC | 428.57K | 707.14K | 0.64% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 932.70K | 1.54M | 1.40% |
2023-06-29 | Vanguard Extended Market Index Fund | 493.68K | 814.56K | 0.74% |
2023-05-30 | Fidelity Extended Market Index Fund | 197.28K | 455.72K | 0.30% |
2023-06-29 | Bridgeway Funds Inc-Ultra Small Company Market Fund | 142.36K | 234.89K | 0.21% |
2023-08-30 | iShares Micro Cap ETF | 92.79K | 152.17K | 0.14% |
2023-05-30 | Fidelity Total Market Index Fund | 78.34K | 180.97K | 0.12% |
$AQST Wish all these day traders would get off the lot.
$AQST Friggen Biden says everything is hunky dory ….he’s an idiot.
$AQST Better days ahead it’s a keeper!
$AQST Now that’s what I’m talking about just keep on punching
$AQST Keep the faith we will be rewarded 20k shares at 4.52avg. And I ride it down to 3.10 and back.
$AQST I’m a believer,done in depth D.D. if your thinking about getting in this is the time I’ve made bundles with Aquestive over the last few years
$AQST Let’s get that $8.06 out of tha way today ,then we can start the run. Stop lookin start buying 76,020 shares ain’t going to do it
$AQST I’ve got a good feeling I think we are going downtown with this baby. Just like last yr but that was to Dallas I’m talking NEW YORK CITY this time.
$AQST 28 Days until Christmas I mean LIFT OFF
$AQST Double your dollar +
$AQST It means we are fixing to make bank big bank keep buying mark my words.
$AQST Way to go John Doe I’m not where you are but I am all in and we are going to make some money Mr.
$AQST CEO stated on 10-06-21 ample cash and credit facilities to carry us through FDA approval and LAUNCH of Libervant . Analysts pinned a middle price target of $17.80 I don’t understand people throwing that kind of easy money away. Smoke um if you got um I guess.
$AQST Someone poke it see if it’s dead
$AQST BCRX I need this to go up $1.24 to off set my losses on BCRX I’m long on both …thanks that .25 will help
$AQST God has spoken PDUFA is 12/23/2021 I’ll be here will you.
$AQST Did I read Trump is getting involved with this?
$AQST Again 10/06/21 CEO states ample cash and Credit Facilities to carry them through FDA approval and LAUNCH of Libervant no offering.
$AQST Step by step inch by inch……..then slowly I